Our research uncovered ROCK1 as an endogenous repressor of TFEB in AD without compromising m-TOR and GSK-3β, providing novel insights into different lysosomal regulation pathways in response to various environmental cues. The gene discussed is ROCK1; the disease is Alzheimer disease.